These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1492778)

  • 1. [Ag-NOR in meningiomas. Clinical and morphologic study of 14 cases].
    Cerdá-Nicolás M; Pérez-Bacet M; Piquer J; Barcia-Salorio JL
    Arch Neurobiol (Madr); 1992; 55(6):251-5. PubMed ID: 1492778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions in meningiomas.
    Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
    Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nucleolar organizer regions in meningiomas with reference to histopathological findings and recurrence].
    Hirayama H; Hara A; Niikawa S; Iwai T; Nishimura Y; Ando T; Sakai N; Yamada H; Takada M
    No To Shinkei; 1993 Apr; 45(4):355-61. PubMed ID: 8334021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of nucleolar organizers staining to the prognostic evaluation of meningioma].
    Kujas M; Capelle L
    Rev Neurol (Paris); 1992; 148(6-7):423-7. PubMed ID: 1448661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
    Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
    Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
    Plate KH; Ruschoff J; Mennel HD
    Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
    Miyagami M; Miyagi A; Kido G; Tsubokawa T
    No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AgNOR in neurooncology].
    Martin H; Gottschalk J; Hufnagl P; Beil M
    Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the nucleolar organizer in tumors of the choroid of the eye].
    Ziangirova GG; Antonova OV; Fedorov AA
    Arkh Patol; 1993; 55(2):44-7. PubMed ID: 7980062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology.
    Rüschoff J; Plate K; Bittinger A; Thomas C
    Pathol Res Pract; 1989 Dec; 185(6):878-85. PubMed ID: 2616372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningiomas: morphologic and ultrastructural characteristics of psammoma bodies].
    Cerdá Nicolás M
    Arch Neurobiol (Madr); 1992; 55(6):256-61. PubMed ID: 1492779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of AgNOR method in predicting recurrence of meningioma.
    Boon AP; Sharif H
    J Clin Pathol; 1989 Sep; 42(9):1002-3. PubMed ID: 2477395
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative evaluation of recurrent meningiomas.
    Scarpelli M; Montironi R; Sisti S; Mariuzzi GM; Brancorsini D; Collan Y; Rychlicki F; Ansuini G
    Pathol Res Pract; 1989 Nov; 185(5):746-51. PubMed ID: 2626384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AgNOR counts in recurrent and non-recurrent meningiomas.
    Bagni A; Botticelli A; Martinelli A; Azzoni P; Trentini GP
    Histopathology; 1991 Nov; 19(5):465-7. PubMed ID: 1757085
    [No Abstract]   [Full Text] [Related]  

  • 16. [Silver staining of nucleolus organizer regions (NORs). Application to the study of nucleolar structure and value in pathology].
    Ploton D; Menager M; Lechki C; Jeannesson P; Visseaux B; Adnet JJ
    Ann Pathol; 1988; 8(3):248-52. PubMed ID: 2460107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the AgNOR technique to neurooncology.
    Plate KH; Rüschoff J; Mennel HD
    Acta Histochem Suppl; 1992; 42():171-8. PubMed ID: 1584962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in pituitary adenomas.
    Radhakrishnan VV; Radhakrishnan NS; Misra BK; Rout D
    Indian J Pathol Microbiol; 1995 Jan; 38(1):25-32. PubMed ID: 8919466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The standardized assessment of argyrophilic nucleolar organizer regions in meningeal tumors.
    Chin LS; Hinton DR
    J Neurosurg; 1991 Apr; 74(4):590-6. PubMed ID: 1705973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.